From CNBC: 2025-05-05 17:47:00

Hims & Hers Health’s shares dropped in after-hours trading despite beating Q1 earnings estimates. Revenue doubled to $586 million, with net income reaching $49.5 million. Q2 revenue guidance of $530-550 million fell short of analyst expectations. The company reported adjusted EBITDA of $91.1 million, surpassing estimates. Collaboration with pharmaceutical players and more partnerships are on the horizon. Former Amazon executive Nader Kabbani joins as COO.



Read more at CNBC:: Hims & Hers (HIMS) Q1 earnings 2025